51.5K
Downloads
56
Episodes
A podcast about the people behind world-leading research at University Health Network, Canada's largest research hospital.
Episodes
Monday Nov 21, 2022
Monday Nov 21, 2022
Dr. Lorraine Kalia’s research looks at testing different compounds in C. Elegans and how it can lead to a better understanding of Parkinson’s disease and new therapeutic targets. The best part: some of these compounds are already approved for use in humans. Through Dr. Kalia’s research we may be able to repurpose these compounds for the neurodegenerative condition.
4 months ago
I was diagnosed with Parkinson’s disease a year ago at the age of 67. For several months I had noticed tremors in my right hand and the shaking of my right foot when I was sitting. My normally beautiful cursive writing was now small, cramped printing. And I tended to lose my balance. The neurologist had me walk down the hall and said I didn’t swing my right arm. I had never noticed! I was in denial for a while, as there is no history in my family of parents and five older siblings, but I had to accept I had classic symptoms. I was taking amantadine and carbidopa/levodopa and was about to start physical therapy to strengthen muscles. I used different supplements that didn’t work, so last July, I tried the PD-5 protocol—the best decision ever! My tremors eased, my energy returned, and I sleep soundly. I feel like a new woman, and I can walk and exercise again. I got the PD-5 from ww w. limitlesshealthcenter. com